Zobrazeno 1 - 10
of 16
pro vyhledávání: '"V V McLaughlin"'
Publikováno v:
European Heart Journal. 43
Background Guidelines for the management of pulmonary arterial hypertension (PAH) recommend early combination therapy of an endothelial receptor antagonist (ERA) and a phosphodiesterase type-5 inhibitor (PDE5i) [1]. There is, however, limited guidanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7092c3b3c6392cc03560c5e54dc6860
https://doi.org/10.1093/eurheartj/ehac544.1916
https://doi.org/10.1093/eurheartj/ehac544.1916
Autor:
V. V. McLaughlin
Publikováno v:
European Journal of Clinical Investigation. 36:10-15
Pulmonary arterial hypertension (PAH) is a devastating disease of the small pulmonary arteries and arterioles, characterized by intimal fibrosis, medial hypertrophy and plexiform lesions. When untreated both the idiopathic form (IPAH, formerly termed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686c355d398c67069fa9d0ed98081722
https://doi.org/10.1111/j.1365-2362.2006.01688.x
https://doi.org/10.1111/j.1365-2362.2006.01688.x
Autor:
D, Khanna, Ma, Tan, D E, Furst, N S, Hill, V V, McLaughlin, R M, Silver, V D, Steen, A, Langer, J R, Seibold, Barbara, Segal
Publikováno v:
Clinical and experimental rheumatology. 32(6 Suppl 86)
The aim of this study was to utilise the Quality Enhancement Research Initiative in Systemic Sclerosis (QuERI-SSc) to measure and reduce a perceived gap in the diagnosis of pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd0854529d02e6e15a51dadcc8c030e6
https://pubmed.ncbi.nlm.nih.gov/24295227
https://pubmed.ncbi.nlm.nih.gov/24295227
Autor:
V V, McLaughlin, S, Rich
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 17(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69afa1e3c005acc0cebac4f186e87462
https://pubmed.ncbi.nlm.nih.gov/9730421
https://pubmed.ncbi.nlm.nih.gov/9730421
Autor:
V V, McLaughlin, S, Rich
Publikováno v:
Comprehensive therapy. 23(9)
When no other explanation for pulmonary hypertension can be found, it is referred to as primary pulmonary hypertension (PPH). Causes of pulmonary hypertension, with a special focus on PPH, as well as recent advances in both its medical and surgical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e384eb1d63719215eca01271c6e2748
https://pubmed.ncbi.nlm.nih.gov/9285162
https://pubmed.ncbi.nlm.nih.gov/9285162
Autor:
V. V. McLaughlin, R. L. Benza, R. J. Barst, V. F. Tapson, Dezheng Huo, Mardi Gomberg-Maitland
Publikováno v:
Journal of Investigative Medicine. 54:S353.4-S353
Purpose The 6-Minute Walk Test (6MW) is the recommended test to assess exercise capacity in pulmonary arterial hypertension (PAH). Metabolic equivalent (MET) is the amount of oxygen used by a seated person and is a predictor of survival in the genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c7702072ab8fa37d5354288dc6a8ee1
https://doi.org/10.2310/6650.2005.x0015.59
https://doi.org/10.2310/6650.2005.x0015.59
Autor:
McLaughlin V; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. vmclaugh@med.umich.edu, Humbert M, Coghlan G, Nash P, Steen V
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2009 Jun; Vol. 48 Suppl 3, pp. iii25-31.
Autor:
Kahan A; Department of Rheumatology A, Cochin Hospital, University of Paris Descartes, AP-HP, Paris, France. andre.kahan@cch.aphp.fr, Coghlan G, McLaughlin V
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2009 Jun; Vol. 48 Suppl 3, pp. iii45-8.
Autor:
Frost AE; Baylor College of Medicine, Houston, TX, United States. frost@bcm.tmc.edu, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V, Robbins IM, Shapiro S, Tapson VF, Zwicke D, DeMarco T, Schilz R, Rubenfire M, Barst RJ
Publikováno v:
Vascular pharmacology [Vascul Pharmacol] 2005 Jun; Vol. 43 (1), pp. 36-9.
Autor:
Harrison RE; Division of Medical Genetics, University of Leicester, Leicester, UK., Flanagan JA, Sankelo M, Abdalla SA, Rowell J, Machado RD, Elliott CG, Robbins IM, Olschewski H, McLaughlin V, Gruenig E, Kermeen F, Halme M, Räisänen-Sokolowski A, Laitinen T, Morrell NW, Trembath RC
Publikováno v:
Journal of medical genetics [J Med Genet] 2003 Dec; Vol. 40 (12), pp. 865-71.